Genetics of rheumatoid arthritis contributes to biology and drug discoveryYukinori Okada, René E. M. Toes, Jian Yang et al.|Nature|2013Cited by 2.5k
Treat-to-target in systemic lupus erythematosus: recommendations from an international task forceRonald van Vollenhoven, Matthias Schneider, Marta Mosca et al.|Annals of the Rheumatic Diseases|2014Cited by 726
A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS)Ronald van Vollenhoven, Murray B. Urowitz, Alexandre E. Voskuyl et al.|Annals of the Rheumatic Diseases|2016Cited by 355
Antidrug antibodies (ADAb) to tumour necrosis factor (TNF)-specific neutralising agents in chronic inflammatory diseases: a real issue, a clinical perspectiveFabien B. Vincent, Christian Marcelli, Eric F. Morand et al.|Annals of the Rheumatic Diseases|2012Cited by 349
Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task forceCindy Strehl, Frank Buttgereit, J. W. J. Bijlsma et al.|Annals of the Rheumatic Diseases|2016Cited by 331